Abstract As angiotensin-converting enzyme inhibition Introduction is accompanied by a marked decrease in glomerular protein loss, the hypothesis was tested that an increase A urinary albumin excretion rate ( UAER) between 30 of the glomerular transcapillary hydraulic pressure and 300 mg 24 h, so-called microalbuminuria, forecasts difference by exogenous angiotensin II would the development of clinically manifest diabetic nephroincrease microalbuminuria in patients with insulin pathy in insulin-dependent (IDDM ) and in non-( IDDM) and non-insulin-dependent diabetes mellitus insulin-dependent diabetes mellitus ( NIDDM ) [1]. ( NIDDM). Acute effects of increasing doses of Newly diagnosed patients with IDDM have an elevangiotensin II (1, 3 and 6 ng/kg/min) were studied on ated glomerular filtration rate (GFR) of 20-50% above mean arterial pressure (MAP), glomerular filtration that of age-matched, non-diabetic subjects [2,3]. The rate (GFR), effective renal plasma flow ( ERPF ), filissue that this so-called hyperfiltration may provoke tration fraction ( FF), total renal vascular resistance proteinuria has been examined further in experiment-( TRVR), and urinary albumin excretion rate ( UAER) ally diabetic rats. Micropuncture studies in streptozotoin 11 IDDM and 11 NIDDM microalbuminuric cin-induced diabetic rats have shown an increased patients. Angiotensin II infusion changed MAP from single-nephron glomerular filtration rate (SNGFR), 100±3 mmHg at baseline to 105±3, 111±3, and and an increased glomerular transcapillary hydraulic 116±3 mmHg (P<0.001), ERPF from 542±29 to pressure difference [4 ]. By analogy, hyperfiltration in 478±24, 429±23, and 382±19 ml/min (P<0.001), FF from 20.2±0.06 to 23.1±0.7, 27.1±1.1, and moderately hyperglycaemic diabetic patients might be 29.8±1.2% (P<0.001), and TRVR from 9454±809 associated with an increase in glomerular transcapillary to 11 158±930, 13 310±1206, and 15 538±1362 hydraulic pressure difference too, and has been postudyne s cm−5 (P<0.001). GFR and UAER, however, lated to contribute to the occurrence of microalbumindid not change significantly. Therefore, during angio-uria in patients with IDDM as well as NIDDM [5 ]. tensin II infusion ERPF decreased, while FF and Angiotensin-converting enzyme (ACE ) inhibitors TRVR increased. As UAER and GFR remained have been shown to normalize intraglomerular capilunchanged, the presumed rise in intraglomerular lary pressure and to prevent the increase in the albumin capillary pressure by exogenous angiotensin II did not excretion rate in experimentally diabetic rats [6 ] and increase UAER. We suggest that during manipulation to decrease microalbuminuria in normotensive adults of the renin-angiotensin system, as in other renal with IDDM [7 ]. Although more than one mechanism diseases with proteinuria, factors other than glomerular is likely to be involved [8], the haemodynamic effect transcapillary hydraulic pressure determine the degree of ACE inhibition has been considered to be largely of urinary albumin loss in microalbuminuric IDDM responsible for the reduction in urinary albumin excreand NIDDM patients.
Mbq 125I-hippuran and 200 mCi/3.7 Mbq 51Cr-EDTA in fraction (FF ) by exogenous angiotensin II would 400 ml saline 0.9%). At the start of the study (t=0 ) a priming increase microalbuminuria in diabetic patients. dose of these radiopharmaceuticals was administered intravenously. Thereafter, a continuous infusion (ImedA type 928) with the dissolved radiopharmaceuticals was started.
Subjects and methods
One and a half hours was allowed for stabilization of the blood glucose and radiopharmaceutical levels. The next 2 h (t=1.5-3.5) were used for baseline clearance studies.
Subjects
After the baseline clearance studies, increasing dosages of angiotensin II ( AII; HypertensinA, Ciba-Geigy AG, Basel, Patients were recruited from our out-patient diabetic clinic Switzerland), 1, 3 and 6 ng AII/kg body weight/min, were after written informed consent. The study protocol had been administered intravenously (PerfusorA ), each for the period approved by the local ethical committee.
of 1 h. Stable AII and aldosterone levels are reached within All patients fulfilled the following criteria before the start 20 min in a normal human [12] . of the study: the presence of microalbuminuria (defined as To ensure adequate diuresis patients drank 200 ml tap an albumin excretion rate of 30-300 mg albumin/24 h shown water each hour. At regular time intervals blood was drawn in at least three out of four 24 h urine specimens), and and urinary samples were taken for measurement of renin, diabetes mellitus ( IDDM or NIDDM ) treated with insulin, AII, GFR, ERPF, and UAER. tolbutamide, glibenclamide or diet only. Exclusion criteria were glycosylated haemoglobin percentage ( HbA 1 c)>12.0%, age<18 or>65 years, serum creatinine>120 mmol/l, diabetes Calculations duration more than 30 years, body mass index >35.0 kg/m2, untreated systolic blood pressure>170 mmHg, untreated dia-FF (%) was determined by the quotient 100×GFR/ERPF. stolic blood pressure>95 mmHg, treatment with antihyper-Mean arterial pressure (MAP, mmHg) was calculated as two tensive or non-steroidal anti-inflammatory drugs, a history times diastolic plus one time systolic blood pressure divided of any renal disease, and females in the fertile period using by three. Renal blood flow (RBF ) was calculated as no adequate contraceptive methods. ERPF/(1−haematocrit), and expressed in l/min. Total A full medical history was taken and a complete physical renal vascular resistance ( TRVR) was calculated as examination performed the day before the start of the study. (MAP/RBF )×80, and expressed in dyne s cm−5. Blood samples for haematological (haematocrit) and chemical measurements (glycosylated haemoglobin; serum creatin-Analytical methods ine) were drawn and determined the same day. A sample of urine was taken for examination of the centrifuged urinary Urinary albumin concentration was measured by RIA (albusediment to exclude urinary tract infection. If any of these min double antibody RIA kit, Diagnostic Products Corp., measurements was seriously aberrant, patients were not Los Angeles, California, USA). accepted for the study.
Plasma AII concentration was measured by RIA (angiotensin II antibody RIA kit, Nichols Institute Diagnostics, Los Angeles, California, USA). Plasma AII concentrations
Study design
greater than 200 pg/ml could not be determined exactly, and are reported as 200 pg/ml in the results. Patients were asked to refrain from strenuous exercise, Plasma renin concentration was measured by RIA (renin smoking and alcoholic beverages for 3 days before the antibody RIA kit, E.R.I.A. Diagnostics Pasteur, Marnes-labeginning of the experiments.
Coquette, France). Plasma renin concentrations smaller than On the day of the experiments patients came to the out-3.5 pg/ml could not be determined exactly and are reported patient clinic after an overnight fast. The morning dose of as 3.5 pg/ml in the data. insulin or oral hypoglycaemic agents had been omitted. All
Radioactivity of plasma and urine samples for measuresubjects remained supine, but during the test it was sometimes ment of GFR and ERPF, and of RIA samples for measurenecessary to permit sitting on the edge of the bed for voiding. ment of urinary albumin concentration, plasma AII and At the beginning of the test (t=0) two intravenous canules renin concentrations, was determined with a gamma scintillawere inserted, one for blood sampling and one for infusion. tion counter ( 2 inch well-type crystal, ICN 3.33, ICN Tracer The blood glucose level (ReflofluxR, Boehringer Mannheim, Lab., Belgium). Mannheim, Germany) was maintained between 4 and Glycosylated haemoglobin percentage ( HbA 1 c) was meas-8 mmol/l by means of a variable glucose and insulin infusion ured by means of high-performance liquid chromatography with, respectively, an InfusomatR Secura and a PerfusorR (HPLC system, Pharmacia/LKB, Uppsala, Sweden). Secura FT (both B. Braun Melsungen AG, Melsungen, Creatinine concentration was measured by means of Germany). The glucose infusion rate was kept constant a Jaffé technique (creatinine kit for BM/Hitachi 717, ( 50 ml/h) and the insulin infusion varied, although sometimes Boehringer Mannheim, Germany). it was necessary to administer a higher rate of glucose infusion. Blood glucose level was measured each 30 min but, if necessary, more often.
Statistical analysis
Blood pressure measurements were performed at 5-10 min intervals with an automatic device (DatascopeR, Datex Data were obtained at each time point of blood and urine sampling from all 22 subjects. The equilibrium period lasted Instrumentarium Corporation, Helsinki, Finland). Electrocardiogram monitoring (Hewlett Packard) was performed 1.5 h from the start of the experiment. The means of the first two measurements of GFR, ERPF, MAP, and UAER were during the whole test period for reasons of safety.
GFR and effective renal plasma flow ( ERPF ) were meas-used as the baseline values for the AII infusion period. For comparison with the AII infusion period results, the ured according to the method of Donker et al.
[ 11] with 125I-hippuran and 51Cr-EDTA (a solution of 200 mCi/3.7 mean baseline value of the above variables was used to correct for individual differences. Analysis of variance with where p A is the afferent colloid osmotic pressure of polynomial contrasts was used to assess changes over time. plasma, P thp the mean glomerular transcapillary A significance level of 0.05 was used for all statistical tests.
hydraulic pressure difference, and Q A the afferent arteriolar plasma flow rate [13] .
In the present study GFR did not change, while
Results
ERPF decreased and FF increased markedly during AII administration. There was no obvious reason for Twenty-three patients participated in the study, but a changed colloid osmotic pressure (p) during the only 22 completed the experiments. The infusions were study. Thus, looking at the above equation, it is prematurely stopped in one patient because he became reasonable to assume an increase in glomerular transcavery upset during the experiment; his data were pillary hydraulic pressure difference during the AII excluded from the analysis.
infusion period. The increase in TRVR during exogenThe clinical and physical characteristics of the ous AII is in agreement with these findings. However, patients are shown in Table 1 . The IDDM patients the lack of an effect of AII infusion on UAER in our with microalbuminuria were younger than the NIDDM study does not support our postulated hypothesis, patients (mean±SD=35±11 and 51±11 years, since the presumed rise in glomerular transcapillary respectively), and had a longer history of diabetes hydraulic pressure did not affect UAER. ( 20±5 and 12±7 years, respectively). Three patients in the NIDDM group were not treated with insulin.
Comparable effects of exogenous AII on urinary Body mass index tended to be lower in IDDM than in albumin excretion have been described previously in NIDDM ( 24.5±2.7 and 27.6±4.1 kg/m2, respectively; patients with chronic renal disease and proteinuria Mann-Whitney U-test, P=0.06). No other differences [9, 10] . Thus, our and other studies suggest that factors could be found between the IDDM and the NIDDM other than changes in renal haemodynamics are also patients for the remaining data.
involved in the antiproteinuric effect of ACE inhibitors. During the whole experiment, apart from the equilib-This suggestion is supported by observations made rium period, blood glucose levels were successfully earlier in experimentally diabetic, spontaneously hypermaintained between 4 and 8 mmol/l in 19 patients. On tensive rats. These rats have a higher intraglomerular one occasion, blood glucose level reached a hypoglyca-pressure compared with normotensive, experimentally emic value 2 h after the start of the experiment, but diabetic rats, but do not develop more proteinuria or that level was immediately corrected. In two other histological damage [14 ] . Conversely, AII infusion cases, blood glucose levels were unstable for approxi-magnifies proteinuria in normal rats [15, 16 ] and in mately 90 min after the equilibrium period, but rats with experimentally glomerular diseases [17, 18] , remained between 2.5 and 8 mmol/l. but the doses of AII used in those rats exceeded Results are shown in Table 2 . GFR did not change markedly the doses of AII used in our and other during the infusion of increasing dosages of AII, but human studies. ERPF decreased significantly. As a consequence, FF Debate exists whether filtration equilibrium, as increased markedly. MAP increased progressively. described above, does exist in humans. If it does not, Therefore, TRVR increased significantly. However, no filtration dysequilibrium implies that the ultrafiltration changes in UAER were observed (P=0.49).
coefficient (K f ) and the tone of the afferent and efferent Compared to baseline values plasma renin concen-arterioles have additional or opposing effects on tration dropped and AII concentration increased SNGFR, SNFF and P thp [8 ] . In the present study AII during the AII infusion period ( Table 3 ) .
was administered in doses leading to a significant increase in MAP. This marked rise in systemic blood Discussion pressure will have resulted in an increased glomerular afferent arteriolar resistance [13 ] . Despite the decrease At filtration pressure equilibrium, SNGFR can be in ERPF, GFR remained essentially unchanged in expressed as: our study. The total rate of glomerular filtration of a single SNGFR=(1−p A /P thp )×Q A nephron independent of equilibrium can be expressed as: hydraulic pressure difference and, therefore, P uf had Glycosylated haemoglobin (%) 9.2±0.3
to increase and K f to decrease for the maintenance of
